Impact on clinic capacity of using aflibercept for neovascular age related macular degeneration (nAMD) in year 2 in Calderdale and Huddersfield NHS Foundation Trust

Ibrahim A. A. H.; Hashmani K.; Blizzard R. M.; Chen Y.; Lane M.; Khan R. S.

首页> 外文期刊>Eye >Impact on clinic capacity of using aflibercept for neovascular age related macular degeneration (nAMD) in year 2 in Calderdale and Huddersfield NHS Foundation Trust

【24h】

Impact on clinic capacity of using aflibercept for neovascular age related macular degeneration (nAMD) in year 2 in Calderdale and Huddersfield NHS Foundation Trust

机译：在Calderdale和Huddersfield NHS基金会信托中，使用AfliBercept用于使用AfliBercept的临床能力与新血管时代相关的黄斑变性（NAMD）

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Eye》 |2017年第2期|共1页
作者
Ibrahim A. A. H.; Hashmani K.; Blizzard R. M.; Chen Y.; Lane M.; Khan R. S.;
展开▼
作者单位

Calderdale &

Huddersfield NHS Trust Acre St Huddersfield HD3 3EA W Yorkshire England;

Calderdale &

Huddersfield NHS Trust Acre St Huddersfield HD3 3EA W Yorkshire England;

Calderdale &

Huddersfield NHS Trust Acre St Huddersfield HD3 3EA W Yorkshire England;

Calderdale &

Huddersfield NHS Trust Acre St Huddersfield HD3 3EA W Yorkshire England;

Calderdale &

Huddersfield NHS Trust Acre St Huddersfield HD3 3EA W Yorkshire England;

Calderdale &

Huddersfield NHS Trust Acre St Huddersfield HD3 3EA W Yorkshire England;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Impact on clinic capacity of using aflibercept for neovascular age related macular degeneration (nAMD) in year 2 in Calderdale and Huddersfield NHS Foundation Trust [J] . Ibrahim A. A. H., Hashmani K., Blizzard R. M., Eye . 2017,第Suppla2期

机译：在Calderdale和Huddersfield NHS基金会信托中，使用AfliBercept用于使用AfliBercept的临床能力与新血管时代相关的黄斑变性（NAMD）
2. Real world data of Anti-VEGF treatment (Aflibercept) in treatment naive Neovascular Age Related Macular Degeneration (nAMD) over 3 years [J] . Chandran Manju, Praveen Sidharth, North Lorraine, Investigative ophthalmology & visual science . 2018,第9期

机译：抗VEGF治疗的真实数据（AFLIBERCEPT）治疗幼脑新生血管时代相关的黄斑变性（NAMD）超过3年
3. Real world data of Anti-VEGF treatment (Aflibercept) in treatment naive Neovascular Age Related Macular Degeneration (nAMD) over 3 years [J] . Chandran Manju, Praveen Sidharth, North Lorraine, Investigative ophthalmology & visual science . 2018,第9期

机译：抗VEGF治疗的真实数据（AFLIBERCEPT）治疗幼脑新生血管时代相关的黄斑变性（NAMD）超过3年
4. Assessment of Choroidal Neovascular Membranes Secondary to Age-Related Macular Degeneration Using Feature Selection [C] . E. Brankin, P.J. McCullagh, W.P. Patton European Conference of the International Federation for Medical and Biological Engineering . 2013

机译：用特征选择评估二次与年龄相关黄斑变性的脉络膜新生血管膜
5. The foundations of community capacity: An exploration of the role of fairness, trust and legitimacy in sustainable watershed management [D] . Sames, Amanda. 2014

机译：社区能力的基础：探讨公平，信任和合法性在可持续流域管理中的作用
6. Corrigendum to Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab [O] . Thi Ha Chau Tran, Stéphane Dumas, Florence Coscas 2018

机译：对Ranibizumab难治性新血管性年龄相关性黄斑变性（nAMD）导致的色素上皮脱离患者Abribercept的两年结局勘误表
7. Corrigendum to “Two-Year Outcome of Aflibercept in Patients with Pigment Epithelial Detachment due to Neovascular Age-Related Macular Degeneration (nAMD) Refractory to Ranibizumab” [O] . Thi Ha Chau Tran, Stéphane Dumas, Florence Coscas 2018

机译：勘察到由于新生血管年龄相关性黄斑脱落（Namd）难治于Ranibizumab的患者患者患有颜料上皮脱离患者的患者的两年后患者的两年后患者“

Impact on clinic capacity of using aflibercept for neovascular age related macular degeneration (nAMD) in year 2 in Calderdale and Huddersfield NHS Foundation Trust

著录项

相似文献

相关主题

期刊订阅